Metformin/Leucine

二甲双胍/亮氨酸

Report date: 2022/07/04 19:38:02

Base Information

Drug NameMetformin/Leucine
Drug Alias Name亮氨酸/二甲双胍Metformin+Leucine亮氨酸+二甲双胍Leucine/Metformin二甲双胍+亮氨酸 +[7] 
ClassificationSmall molecules
Mechanisms of ActionProtein kinase AMP-activated non-catalytic subunit beta 1 activators
TargetsProtein kinase AMP-activated non-catalytic subunit beta 1
Therapy Area/IndicationsDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsYes Metformin Hydrochloride
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNusirt Biopharma
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNusirt Biopharma
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus, Type 2

Other Information

ATC CodeN/A
Related LinksN/A